EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE: NYSE:WST), a company specializing in solutions for injectable drug administration, has declared a quarterly dividend of $0.20 per share for the second quarter of 2024. This dividend is scheduled for payment on May 1, 2024, to shareholders who are on record as of April 24, 2024.
The announcement underscores West Pharmaceutical's ongoing commitment to providing value to its shareholders. The company, known for its role in the healthcare sector, helps to ensure the containment and delivery of medications through its production of components and devices. With a workforce of 10,000 across 50 global sites, West Pharmaceutical produced approximately 48 billion components and devices in the past year.
In the fiscal year 2023, West Pharmaceutical reported net sales of $2.95B. The company's performance and its inclusion in the Standard & Poor's 500 index reflect its standing in the industry. West Pharmaceutical is headquartered in Exton, Pennsylvania, and its shares are publicly traded on the New York Stock Exchange.
The dividend announcement is based on a press release statement from West Pharmaceutical Services, Inc. The company's commitment to shareholder returns is consistent with its financial performance and strategic goals. West Pharmaceutical continues to play a significant role in the pharmaceutical supply chain, providing critical components for drug delivery systems.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.